IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q3 2025 Holdings

Filed 2025-11-10 | 4 holdings | $55.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tourmaline BIO Inc(TRML)COM89157D105$35.5M741,69163.8%
Korro BIO Inc(KRRO)COM500946108$17.6M368,08531.7%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$2.2M928,9644.0%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$323.2K82,8710.6%